We retrospectively investigated the efficacy of the MELD score to predict the outcome of liver retransplantation and serve as selection criteria. From 1987 to 2003, the 765 liver transplantations included 87 patients (11.4%) who received a second graft. In addition to graft and patient survivals, ROC curves were used to establish the best MELD score to select cases with poor outcomes. Indications for retransplantation were: 38 (43.7%) surgical complications; 12 (13.8%) chronic rejections; 15 (17.2%) disease recurrences; and 22 (15.3%) primary graft nonfunction. Overall patient survivals at 1, 3, and 5 years were 62.4%, 50.7%, and 49.1%, respectively. A MELD score of 25, calculated by ROC curves, significantly predicted graft and patient survival (44.2% vs 22.5%, P <. 05 and 58.6% vs 27.8%, P <. 005). During the first 30 postoperative days, patients with a MELD higher than 25 lost the second graft in 48% of cases compared to 16% in the other group (P <. 005). Patients retransplanted for primary graft nonfunction showed significant lower 5-year survival rates than those for other indications (28.6% vs 54.5%, P <. 05) and higher mean MELD score (30.7 vs 21.9, P <. 05). A MELD score of 25 is a valid cut-off to predict the outcome of retransplantations, it may be useful to select patients among those who require a second graft. Cases with primary graft nonfunction displayed lower survival, because of their compromised clinical status as evidenced by their high MELD scores.

Efficacy of MELD score in predicting survival after liver retransplantation / RAVAIOLI, MATTEO; GRAZI, GIAN LUCA; ERCOLANI, GIORGIO; CESCON, MATTEO; VAROTTI, GIOVANNI; DEL GAUDIO, MASSIMO; VETRONE, GAETANO; Lauro A; Ballardini G; PINNA, ANTONIO DANIELE. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - STAMPA. - 36:(2004), pp. 2748-2749. [10.1016/j.transproceed.2004.09.051]

Efficacy of MELD score in predicting survival after liver retransplantation

GRAZI, GIAN LUCA;
2004

Abstract

We retrospectively investigated the efficacy of the MELD score to predict the outcome of liver retransplantation and serve as selection criteria. From 1987 to 2003, the 765 liver transplantations included 87 patients (11.4%) who received a second graft. In addition to graft and patient survivals, ROC curves were used to establish the best MELD score to select cases with poor outcomes. Indications for retransplantation were: 38 (43.7%) surgical complications; 12 (13.8%) chronic rejections; 15 (17.2%) disease recurrences; and 22 (15.3%) primary graft nonfunction. Overall patient survivals at 1, 3, and 5 years were 62.4%, 50.7%, and 49.1%, respectively. A MELD score of 25, calculated by ROC curves, significantly predicted graft and patient survival (44.2% vs 22.5%, P <. 05 and 58.6% vs 27.8%, P <. 005). During the first 30 postoperative days, patients with a MELD higher than 25 lost the second graft in 48% of cases compared to 16% in the other group (P <. 005). Patients retransplanted for primary graft nonfunction showed significant lower 5-year survival rates than those for other indications (28.6% vs 54.5%, P <. 05) and higher mean MELD score (30.7 vs 21.9, P <. 05). A MELD score of 25 is a valid cut-off to predict the outcome of retransplantations, it may be useful to select patients among those who require a second graft. Cases with primary graft nonfunction displayed lower survival, because of their compromised clinical status as evidenced by their high MELD scores.
2004
36
2748
2749
RAVAIOLI, MATTEO; GRAZI, GIAN LUCA; ERCOLANI, GIORGIO; CESCON, MATTEO; VAROTTI, GIOVANNI; DEL GAUDIO, MASSIMO; VETRONE, GAETANO; Lauro A; Ballardini G...espandi
File in questo prodotto:
File Dimensione Formato  
2004 (Tranpl Proc) Ravaioli - Re-OLT-MELD.pdf

Accesso chiuso

Dimensione 57.76 kB
Formato Adobe PDF
57.76 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1301348
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 18
social impact